{"id":"W2622354226","doi":"10.1002/hon.2437_76","title":"CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Salvage therapy; Interim analysis; Oncology; Clinical endpoint; Gemcitabine; Febrile neutropenia; Diffuse large B-cell lymphoma; Population; Neutropenia; Ibrutinib; Chemotherapy regimen; Surgery; Chemotherapy; Randomized controlled trial; Lymphoma; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002618583,0.001821019,0.002399324,0.0004156542,0.0008820234,0.001169329,0.001213058,0.001915559,0.009096562],"category_scores_gemma":[0.001775999,0.0005096964,0.001773194,0.0008309856,0.001204571,0.0005108828,0.000465402,0.003676388,0.001249911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004666316,"about_ca_system_score_gemma":0.01192897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05035957,"about_ca_topic_score_gemma":0.1499393,"domain_scores_codex":[0.9992328,0.0003790582,0.00002598622,0.0001028032,0.0001250865,0.0001343524],"domain_scores_gemma":[0.9990466,0.000135998,0.0002022665,0.00006197614,0.0001301986,0.0004229448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9076625,0.01011642,0.00292222,0.002451529,0.002061327,0.000152086,0.0001700071,0.000924024,0.004059155,0.000641208,0.01867011,0.05016951],"study_design_scores_gemma":[0.9565618,0.0340093,0.00324536,0.00009630129,0.000653587,0.00006989976,0.00002734569,0.0003043404,0.0002527806,0.0001736857,0.004588005,0.00001750508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9045854,0.0194857,0.001182673,0.007211948,0.001511796,0.03650774,0.01555166,0.0004096477,0.01355335],"genre_scores_gemma":[0.8934196,0.0134073,0.007764865,0.01018476,0.001072068,0.04060752,0.01574785,0.0001487336,0.01764722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05035957,"threshold_uncertainty_score":0.1001329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1357148248903003,"score_gpt":0.442831365213154,"score_spread":0.3071165403228537,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}